Detailed Information
Cited 0 time in 
Cited 152 time in 
Cited 152 time in
Metadata Downloads
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Koreaopen access
- Authors
- Kim, Mee Kyoung; Ko, Seung-Hyun; Kim, Bo-Yeon; Kang, Eun Seok; Noh, Junghyun; Kim, Soo-Kyung; Park, Seok-O; Hur, Kyu Yeon; Chon, Suk; Moon, Min Kyong; Kim, Nan-Hee; Kim, Sang Yong; Rhee, Sang Youl; Lee, Kang-Woo; Kim, Jae Hyeon; Rhee, Eun-Jung; Chun, SungWan; Yu, Sung Hoon; Kim, Dae Jung; Kwon, Hyuk-Sang; Park, Kyong Soo
- Issue Date
- Aug-2019
- Publisher
- 대한당뇨병학회
- Keywords
- Diabetes mellitus; type 2; Diagnosis; Practice guideline; Therapeutics
- Citation
- Diabetes and Metabolism Journal, v.43, no.4, pp 398 - 406
- Pages
- 9
- Journal Title
- Diabetes and Metabolism Journal
- Volume
- 43
- Number
- 4
- Start Page
- 398
- End Page
- 406
- ISSN
- 2233-6079
2233-6087
- Abstract
- The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Bo Yeon
- College of Medicine (Department of Internal Medicine)